Word: pneumonia
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Thirty years back we used plain films to diagnose nearly everything - appendicitis, kidney stones, pneumonia, broken bones - and an X-ray alone was enough. We took care of them all just using plain films. Today, however, there's a good chance that after ordering up that plain film, the emergency doctor will send you down the hall for a second test - one that exposes you to many hundreds of times the radiation of a plain film: a CT scan. The radiation from a CT scan, or computed tomography, actually has been shown to cause cancer - quite...
Merck is pulling 11 lots of PedvaxHIB and two lots of COMVAX. PedvaxHIB is a vaccine that protects against infection with haemophilus influenzae type B (Hib), the bacteria that causes meningitis, pneumonia, and bloodstream infections. The COMVAX vaccine protects against haemophilius B and hepatitis B, a virus that can cause liver disease...
...disease (a major cause of meningitis) had all fallen more than 99% since vaccines were introduced against them. Vaccines have cut the number of deaths from hepatitis A, acute hepatitis B, and chickenpox by more than 80% each. And deaths from invasive pneumococcal disease (a cause of pneumonia, meningitis, and blood infection) have been cut by a quarter. Smallpox has been eradicated worldwide...
...American Medical Association found that MRSA is more prevalent than any previous estimates had suggested. In the CDC's survey of nine states in 2005, there were 32 cases of MRSA infection for every 100,000 people. (By comparison, in that same year, the incidence of invasive pneumonia or flu infections ranged from less than one to 14 cases per 100,000 people.) Extrapolating from these states' statistics, the researchers estimated that there were 94,300 cases of MRSA in the entire U.S. in 2005, with 18,600 deaths. The majority of these cases - 85% of them - occurred in health...
...communities in need. John J. Mekalanos, chair of the Harvard Medical School’s Department of Microbiology and Molecular Genetics, developed a cheaper, faster technique for manufacturing conjugate vaccines, which protect against multiple diseases caused by bacteria such as pneumococcus, which can cause everything from ear infections to pneumonia. The vaccines’ capacity to protect against a variety of diseases at once makes them particularly valuable in developing parts of the world. The only such vaccine currently available to fight these diseases—Prevnar, produced by the pharmaceutical company Wyeth—remains too costly...